Importantly, chronic exposure of DLBCL or FL cells to venetoclax results in acquired resistance due to AKT activation and upregulation of MCL-1 and BCL-xL levels that sequestered BIM55,81. The gene discussed is AKT1; the disease is diffuse large B-cell lymphoma.